Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Some cancers need growth factors which are made by the body's white blood cells to
keep growing.Anakinra may interfere with the growth factor and stop multiple myeloma from
growing. Dexamethasone may stop cancer cells from growing. Giving anakinra together with
dexamethasone may be an effective treatment for multiple myeloma.
PURPOSE: This phase II trial is studying how well anakinra works when given with or without
dexamethasone in treating patients with smoldering myeloma or indolent multiple myeloma.